HomeDBVT • NASDAQ
DBV Technologies SA - ADR
$0.74
Mar 28, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
US listed security
Previous close
$0.76
Day range
$0.72 - $0.76
Year range
$0.65 - $2.37
Market cap
132.69M USD
Avg Volume
67.59K
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
8.88M780.60%
Operating expense
20.80M-43.36%
Net income
-11.19M71.49%
Net profit margin
-126.04-104.19%
Earnings per share
-0.20
EBITDA
-8.63M66.80%
Effective tax rate
0.05%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
141.37M-32.42%
Total assets
182.99M-25.77%
Total liabilities
42.80M-17.80%
Total equity
140.19M
Shares outstanding
96.21M
Price to book
0.52
Return on assets
-15.99%
Return on capital
-20.45%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-11.19M71.49%
Cash from operations
-13.69M42.70%
Cash from investing
-187.00K-450.00%
Cash from financing
-189.00K33.22%
Net change in cash
-7.77M-123.48%
Free cash flow
-8.65M22.47%
About
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
Founded
Mar 29, 2002
Employees
105
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu